URMC / Research / Health Research /Clinical Trials / Study Details

UBMT17044 / HBO-UBC / Omar Aljitawi

Research Question:
Will the use of hyperbaric oxygen (HBO) therapy prior to the UCB transplant improve the stem cell homing, and subsequently, the engraftment?

Basic Study Information

Purpose:
The UCB transplant is a type of stem cell transplant used to treat cancer of the blood or lymph glands. The UCB transplant has advantages over other types of transplants such as ease of obtaining the umbilical cord blood, absence of donor risks, reduced risks of contagious infections, and the availability for immediate use. The UCB transplant is also associated with a lower incidence of graft versus host disease, or GvHD (in GvHD, the transplanted graft attacks the recipient organs).

Location: University of Rochester Medical Center
Study Reference #: UBMT17044

Lead Researcher (Principal Investigator)

Lead Researcher: Omar Aljitawi

Study Contact Information

Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu

Additional Study Details

Contact This Study

First Name *

This field is required

Middle Name

Last Name *

This field is required

Phone Number

I agree to be contacted by The University of Rochester Medical Center regarding participation in this study. *

You must agree to be contacted to continue.

Please call me during the day.

Please call me during the evening.

Message

Return to Search

Research

UR Health Research